While the current study did not assess NF1 mRNA for correlation, this may indicate a subset of glioblastoma is inactivating NF1 post-transcriptionally through mechanisms such as proteasomal degradation or post-transcriptional silencing, or through other negative feedback mechanisms. The gene discussed is NF1; the disease is glioblastoma.